Mucocutaneous findings associated with interleukin (IL)-17 inhibition
نویسندگان
چکیده
منابع مشابه
Mucocutaneous findings associated with interleukin (IL)-17 inhibition
SAE: serious adverse event INTRODUCTION Sialadenitis, inflammation of a salivary gland, typically presents with pain, swelling, and erythema of the oral mucosa. In particular, lymphocytic sialadenitis is most commonly associated with Sj€ ogren’s syndrome and hepatitis C viral infection but has never been described in the setting of interleukin (IL)-17 inhibition. We report a case of lymphocytic...
متن کاملChronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity
Chronic mucocutaneous candidiasis (CMC) is characterized by recurrent or persistent infections affecting the nails, skin and oral and genital mucosae caused by Candida spp., mainly Candida albicans. CMC is an infectious phenotype in patients with inherited or acquired T-cell deficiency. Patients with autosomal-dominant (AD) hyper IgE syndrome (HIES), AD signal transducer and activator of transc...
متن کاملInterleukin-17 family and IL-17 receptors.
Interleukin-17 (IL-17) is a pro-inflammatory cytokine secreted by activated T-cells. Recently discovered related molecules are forming a family of cytokines, the IL-17 family. The prototype member of the family has been designated IL-17A. Due to recent advances in the human genome sequencing and proteomics five additional members have been identified and cloned: IL-17B, IL-17C, IL-17D, IL-17E a...
متن کاملInterleukin-17 inhibition in psoriatic arthritis.
Greater understanding of the underlying disease process has led to the development of targeted therapeutic agents and innovative strategies in the treatment of psoriatic arthritis (PsA). This report addresses novel medications targeting the T helper 17 cell pathway, specifically those inhibiting interleukin-17A and its receptor, and discusses their role as effective therapies in the management ...
متن کاملThe Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans.
The discovery of interleukin (IL)-17-mediated immunity has provided a robust framework upon which our current understanding of the mechanism involved in host defense against mucocutaneous candidiasis (CMC) has been built. Studies have shed light on how pattern recognition receptors expressed by innate immune cells recognize various components of Candida cell wall. Inborn errors of immunity affe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAAD Case Reports
سال: 2016
ISSN: 2352-5126
DOI: 10.1016/j.jdcr.2015.11.012